Artiva Biotherapeutics Statistics

Total Valuation

ARTV has a market cap or net worth of $51.41 million. The enterprise value is -$101.29 million.

Market Cap	51.41M
Enterprise Value	-101.29M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

ARTV has 24.36 million shares outstanding. The number of shares has increased by 2,024.91% in one year.

Current Share Class	24.36M
Shares Outstanding	24.36M
Shares Change (YoY)	+2,024.91%
Shares Change (QoQ)	-0.18%
Owned by Insiders (%)	0.26%
Owned by Institutions (%)	25.17%
Float	4.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.30
P/TBV Ratio	0.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.93, with a Debt / Equity ratio of 0.08.

Current Ratio	13.93
Quick Ratio	13.62
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -68.14% and return on invested capital (ROIC) is -38.92%.

Return on Equity (ROE)	-68.14%
Return on Assets (ROA)	-33.30%
Return on Invested Capital (ROIC)	-38.92%
Return on Capital Employed (ROCE)	-41.86%
Revenue Per Employee	n/a
Profits Per Employee	-$805,854
Employee Count	89
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	3.28
200-Day Moving Average	8.52
Relative Strength Index (RSI)	39.34
Average Volume (20 Days)	207,323

Short Selling Information

The latest short interest is 1.46 million, so 5.98% of the outstanding shares have been sold short.

Short Interest	1.46M
Short Previous Month	1.44M
Short % of Shares Out	5.98%
Short % of Float	33.16%
Short Ratio (days to cover)	2.31

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-74.96M
Pretax Income	n/a
Net Income	-71.72M
EBITDA	-72.49M
EBIT	-74.96M
Earnings Per Share (EPS)	-$4.18

Full Income Statement

Balance Sheet

The company has $165.96 million in cash and $14.00 million in debt, giving a net cash position of $151.97 million or $6.24 per share.

Cash & Cash Equivalents	165.96M
Total Debt	14.00M
Net Cash	151.97M
Net Cash Per Share	$6.24
Equity (Book Value)	168.78M
Book Value Per Share	6.93
Working Capital	157.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$59.79 million and capital expenditures -$1.14 million, giving a free cash flow of -$60.92 million.

Operating Cash Flow	-59.79M
Capital Expenditures	-1.14M
Free Cash Flow	-60.92M
FCF Per Share	-$2.50

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARTV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,024.91%
Shareholder Yield	-2,024.91%
Earnings Yield	-141.53%
FCF Yield	-120.22%

Analyst Forecast

The average price target for ARTV is $20.00, which is 847.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	847.87%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARTV has an Altman Z-Score of 3.84 and a Piotroski F-Score of 2.

Altman Z-Score	3.84
Piotroski F-Score	2